CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Singleton pregnancy
  • ✓Gestational age 34–36 weeks by date and last menstrual period
  • ✓Normal amniotic fluid index
Key exclusion· 5
  • ✕Multiple pregnancies
  • ✕Oligohydramnios or polyhydramnios (AFI >95th percentile or <5th percentile)
  • ✕Obesity (BMI >30)
  • ✕Intrauterine growth restriction

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02643199
NCT02643199N/ACompleted
CompareCT.gov

Automated Fetal Heart Echocardiography by Five-Dimensional Ultrasound in the Third Trimester of Pregnancy

Ain Shams University·observational·Posted Dec 31, 2015·Updated Jul 14, 2017

In Brief

An observational study for Fetal Heart Echocardiography by Five Dimensional Ultrasound. Completed, enrolled 90 participants.

Detailed Summary

The aim of the study to evaluate Five-Dimensional Ultrasound in automated assessment of the fetal heart from 20-36 weeks of gestation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFetal Heart Echocardiography by Five Dimensional Ultrasound
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedDec 31, 2015
Enrollment StartDec 1, 2015
Primary CompletionAug 1, 2016
Study CompletionSep 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.5 years ago